Clinical Trials Browser

Phase 3 × OTHER × Papillomavirus Vaccines × Clear all

NCT05173324 2022-08-03

H2VICTORY

Phase 3 Not yet recruiting

HIV Infections, Papillomavirus Infections

NCT01735006 2020-02-24

Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine

Phase 3 Completed

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT00501137 2015-04-10

BCGov-01

Phase 3 Completed

Uterine Cervical Neoplasms, Condylomata Acuminata